Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Colorectal Neoplasms

Free Subscription Articles published in Hum Pathol Retrieve available abstracts of 35 articles: HTML format

Single Articles

March 2024
1. HO YH, Hsu CY, Yau Li AF, Liang WY, et al
   Colorectal neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm: Prognostic factors and PD-L1 expression.
   Hum Pathol. 2024;145:80-85.
   PubMed     Abstract available
   
   
   
2. VOS AM, Pijnenborg L, van Vliet S, Kodach LL, et al
   Biological background of colorectal polyps and carcinomas with heterotopic ossification: A national study and literature review.
   Hum Pathol. 2024;145:34-41.
   PubMed     Abstract available
   
   
   
3. SUGAI T, Uesugi N, Osakabe M, Yao T, et al
   Characterization of sessile serrated adenomas with dysplasia including intramucosal adenocarcinoma and colorectal carcinoma with a microsatellite instability phenotype.
   Hum Pathol. 2024;145:9-15.
   PubMed     Abstract available
   
   
   February 2024
4. PIHLMANN KRISTENSEN M, Korsgaard U, Timm S, Hansen TF, et al
   The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program.
   Hum Pathol. 2024 Feb 28:S0046-8177(24)00033.
   PubMed     Abstract available
   
   
   
5. OZEKI H, Shimada Y, Nakano M, Kondo S, et al
   Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer.
   Hum Pathol. 2024 Feb 27:S0046-8177(24)00032.
   PubMed     Abstract available
   
   
   
6. JEPSEN DNM, Hoeg H, Bzorek M, Orhan A, et al
   Digitally assessed lymphocyte infiltration in rectal cancer biopsies is associated with pathological response to neoadjuvant therapy.
   Hum Pathol. 2024;144:61-70.
   PubMed     Abstract available
   
   
   November 2023
7. CARLIN L, Paudice M, Ingaliso M, Pigozzi S, et al
   Synchronous and metachronous primary colorectal cancers with concordant and discordant mismatch repair status.
   Hum Pathol. 2023;141:54-63.
   PubMed     Abstract available
   
   
   
8. YOSHIDA M, Suwa T, Shimada S, Shiotsuki K, et al
   Desmin immunostaining is effective for improving interobserver variability in the depth assessment of the submucosal invasion of colorectal cancers.
   Hum Pathol. 2023;141:149-157.
   PubMed     Abstract available
   
   
   July 2023
9. BOYLAN KE, Kanth P, Delker D, Hazel MW, et al
   Three pathologic criteria for reproducible diagnosis of colonic sessile serrated lesion versus hyperplastic polyp.
   Hum Pathol. 2023;137:25-35.
   PubMed     Abstract available
   
   
   May 2023
10. HARPAZ N, Goldblum JR, Shepherd NA, Riddell RH, et al
    Colorectal dysplasia in chronic inflammatory bowel disease: A contemporary consensus classification and interobserver study.
    Hum Pathol. 2023 May 27:S0046-8177(23)00119.
    PubMed     Abstract available
    
    
    
11. MACKINNON AC JR, Johnson CM, Robin A, Christiansen L, et al
    Pathologic, Immunologic, and Clinical Analysis of the Microsatellite Instability Phenotype in Endometrial Carcinoma.
    Hum Pathol. 2023 May 26:S0046-8177(23)00122.
    PubMed     Abstract available
    
    
    
12. MATSUBAYASHI H, Oishi T, Sasaki K, Abe M, et al
    Discordance of microsatellite instability and mismatch repair immunochemistry occurs depending on the cancer type.
    Hum Pathol. 2023;135:54-64.
    PubMed     Abstract available
    
    
    April 2023
13. FREITAG CE, Chen W, Pearlman R, Hampel H, et al
    Mismatch Repair Protein Status of Non-Neoplastic Uterine and Intestinal Mucosa in Patients with Lynch Syndrome and Double Somatic Mismatch Repair Protein Mutations.
    Hum Pathol. 2023 Apr 6:S0046-8177(23)00080-1. doi: 10.1016/j.humpath.2023.
    PubMed     Abstract available
    
    
    February 2023
14. DHALL D, Makhoul E, Taguibao R, Waters K, et al
    Molecular Characterization of Visible Low Grade Dysplastic lesions in Patients with Inflammatory Bowel disease.
    Hum Pathol. 2023 Feb 6:S0046-8177(23)00028-X. doi: 10.1016/j.humpath.2023.
    PubMed     Abstract available
    
    
    
15. VYAS M, Gonzalez RS
    Anal intraepithelial neoplasia: a review of terminology, differential diagnoses, and patient management.
    Hum Pathol. 2023;132:56-64.
    PubMed     Abstract available
    
    
    
16. LUCHINI C, Scarpa A
    Microsatellite instability in pancreatic and ampullary carcinomas: histology, molecular pathology, and clinical implications.
    Hum Pathol. 2023;132:176-182.
    PubMed     Abstract available
    
    
    December 2022
17. BUSHARA O, Wester J, Jacobsen D, Sun L, et al
    Clinical and Histopathologic Characterization of SETD2-Mutated Colorectal Cancer.
    Hum Pathol. 2022 Dec 8:S0046-8177(22)00279-9. doi: 10.1016/j.humpath.2022.
    PubMed     Abstract available
    
    
    November 2022
18. ZHANG Z, Pang J, Chen L, Chen J, et al
    Pan-tropomyosin receptor kinase immunohistochemistry is a feasible routine screening strategy for NTRK fusions in mismatch repair-deficient colorectal carcinomas.
    Hum Pathol. 2022;129:21-31.
    PubMed     Abstract available
    
    
    October 2022
19. BUSHARA O, Weinberg SE, Finkelman BS, Jiang H, et al
    The effect of human immunodeficiency virus and human papillomavirus strain diversity on the progression of anal squamous intraepithelial lesions.
    Hum Pathol. 2022;128:20-30.
    PubMed     Abstract available
    
    
    September 2022
20. YAMADA A, Yamamoto Y, Minamiguchi S, Kamada M, et al
    Clinicopathological and molecular characterization of deficient mismatch repair colorectal cancer.
    Hum Pathol. 2022 Sep 20. pii: S0046-8177(22)00238.
    PubMed     Abstract available
    
    
    July 2022
21. LIBERA L, Sahnane N, Pepe F, Pisapia P, et al
    Critical aspects of MSI testing in endometrial cancer: a comparison study.
    Hum Pathol. 2022 Jul 21. pii: S0046-8177(22)00187.
    PubMed     Abstract available
    
    
    
22. JAKAB A, Patai AV, Micsik T
    Digital image analysis provides robust tissue microenvironment-based prognosticators in stage I-IV colorectal cancer patients.
    Hum Pathol. 2022 Jul 9. pii: S0046-8177(22)00176.
    PubMed     Abstract available
    
    
    
23. HELDERMAN NC, Elsayed FA, van Wezel T, Terlouw D, et al
    Mismatch repair deficiency and MUTYH variants in small intestine-neuroendocrine tumors.
    Hum Pathol. 2022;125:11-17.
    PubMed     Abstract available
    
    
    June 2022
24. WATERS KM, Singhi AD, Montgomery EA
    Exploring the Spectrum of Serrated Epithelium Encountered in Inflammatory Bowel Disease.
    Hum Pathol. 2022 Jun 23. pii: S0046-8177(22)00163.
    PubMed     Abstract available
    
    
    
25. ISLAM RONEY MS, Lanagan C, Sheng Y, Gough M, et al
    Isotypic analysis of anti-p53 serum autoantibodies and p53 protein tissue phenotypes in colorectal cancer.
    Hum Pathol. 2022 Jun 21. pii: S0046-8177(22)00162.
    PubMed     Abstract available
    
    
    May 2022
26. ALEXANDER PG, Matly AAM, Jirapongwattana N, Pennel KAF, et al
    The relationship between the Glasgow Microenvironment Score and Markers of Epithelial-to-Mesenchymal Transition in TNM II-III Colorectal Cancer.
    Hum Pathol. 2022 May 24. pii: S0046-8177(22)00140.
    PubMed     Abstract available
    
    
    
27. NEWLAND R, Ng KS, Chapuis P, Chan C, et al
    The Association Between Tumour Sub-site and Local Nodal and/or Distant Metastasis at the Time of Resection of Colorectal Cancer: A prospective study of 3,360 consecutive cases.
    Hum Pathol. 2022 May 9. pii: S0046-8177(22)00120.
    PubMed     Abstract available
    
    
    April 2022
28. CHENG T, Gamage SMK, Hewage D, Lu CT, et al
    AHR gene expression and the polymorphism rs2066853 are associated with clinicopathological parameters in colorectal carcinoma.
    Hum Pathol. 2022;122:50-59.
    PubMed     Abstract available
    
    
    
29. CHEZAR K, Minoo P
    Appendiceal sessile serrated lesions are distinct from their right-sided colonic counterparts and may be precursors for appendiceal mucinous neoplasms.
    Hum Pathol. 2022;122:40-49.
    PubMed     Abstract available
    
    
    March 2022
30. ABE H, Yasunaga Y, Yamazawa S, Nakai Y, et al
    Histological growth patterns of colorectal cancer liver metastases: a strong prognostic marker associated with invasive patterns of the primary tumor and p53 alteration.
    Hum Pathol. 2022 Mar 2. pii: S0046-8177(22)00048.
    PubMed     Abstract available
    
    
    January 2022
31. ESCOBAR D, Bushara O, Sun L, Liao J, et al
    Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
    Hum Pathol. 2022;119:51-58.
    PubMed     Abstract available
    
    
    December 2021
32. LAYCOCK A, Kang A, Ang S, Texler M, et al
    Lack of correlation between MSH3 immunohistochemistry and microsatellite analysis for the detection of elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) in colorectal cancers.
    Hum Pathol. 2021;118:9-17.
    PubMed     Abstract available
    
    
    October 2021
33. SNOW SM, Matkowskyj KA, Maresh M, Clipson L, et al
    Validation of genetic classifiers derived from mouse and human tumors to identify molecular subtypes of colorectal cancer.
    Hum Pathol. 2021 Oct 13. pii: S0046-8177(21)00180.
    PubMed     Abstract available
    
    
    August 2021
34. BOCCIARELLI C, Caumont C, Samaison L, Cariou M, et al
    MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories.
    Hum Pathol. 2021;114:99-109.
    PubMed     Abstract available
    
    
    March 2021
35. SINGHI AD, Waters KM, Makhoul EP, Parian A, et al
    Targeted Next-Generation Sequencing Supports Serrated Epithelial Change as an Early Precursor to Inflammatory Bowel Disease-Associated Colorectal Neoplasia.
    Hum Pathol. 2021 Mar 13. pii: S0046-8177(21)00043.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.